A Dose Blind, Multi-Center, Extension Study to Determine the Long-Term Safety and Efficacy of Two Doses of BG00012 Monotherapy in Subjects With Relapsing-Remitting Multiple Sclerosis

The PI of this project was:

This project was funded by: Biogen Idec

The term of this project was: February 2015 to January 2013

The number of subjects scanned during this project was: 6